[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

EMEA (Europe, Middle East and Africa) Granulocyte-Colony Stimulating Factor Market Report 2017

November 2017 | 113 pages | ID: EF6D7DE2758EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA Granulocyte-Colony Stimulating Factor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Granulocyte-Colony Stimulating Factor for these regions, from 2012 to 2022 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Granulocyte-Colony Stimulating Factor market competition by top manufacturers/players, with Granulocyte-Colony Stimulating Factor sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Biocad
  • Celltrion Inc
  • Dong-A Socio Group
  • Pfizer Inc
  • Intas Pharmaceuticals Ltd
  • Novartis
  • Stada Arzneimittel AG
  • Teva Pharmaceutical Industries Ltd
  • Amgen Inc
  • Biocon
  • Dr. Reddy's Laboratories
  • Mylan
  • Merck KGaA
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Capsule
  • Tablet
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Oncology
  • Blood Disorders
  • Growth Hormone Deficiencies
  • Chronic and Autoimmune Disorders
  • Other Applications
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) Granulocyte-Colony Stimulating Factor Market Report 2017

1 GRANULOCYTE-COLONY STIMULATING FACTOR OVERVIEW

1.1 Product Overview and Scope of Granulocyte-Colony Stimulating Factor
1.2 Classification of Granulocyte-Colony Stimulating Factor
  1.2.1 EMEA Granulocyte-Colony Stimulating Factor Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Granulocyte-Colony Stimulating Factor Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Capsule
  1.2.4 Tablet
  1.2.5 Others
1.3 EMEA Granulocyte-Colony Stimulating Factor Market by Application/End Users
  1.3.1 EMEA Granulocyte-Colony Stimulating Factor Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Oncology
  1.3.3 Blood Disorders
  1.3.4 Growth Hormone Deficiencies
  1.3.5 Chronic and Autoimmune Disorders
  1.3.6 Other Applications
1.4 EMEA Granulocyte-Colony Stimulating Factor Market by Region
  1.4.1 EMEA Granulocyte-Colony Stimulating Factor Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Granulocyte-Colony Stimulating Factor (2012-2022)
  1.5.1 EMEA Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2012-2022)

2 EMEA GRANULOCYTE-COLONY STIMULATING FACTOR COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Granulocyte-Colony Stimulating Factor Market Competition by Players/Manufacturers
  2.1.1 EMEA Granulocyte-Colony Stimulating Factor Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Granulocyte-Colony Stimulating Factor Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Granulocyte-Colony Stimulating Factor Sale Price by Players (2012-2017)
2.2 EMEA Granulocyte-Colony Stimulating Factor (Volume and Value) by Type/Product Category
  2.2.1 EMEA Granulocyte-Colony Stimulating Factor Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Granulocyte-Colony Stimulating Factor Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Granulocyte-Colony Stimulating Factor Sale Price by Type (2012-2017)
2.3 EMEA Granulocyte-Colony Stimulating Factor (Volume) by Application
2.4 EMEA Granulocyte-Colony Stimulating Factor (Volume and Value) by Region
  2.4.1 EMEA Granulocyte-Colony Stimulating Factor Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Granulocyte-Colony Stimulating Factor Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Granulocyte-Colony Stimulating Factor Sales Price by Region (2012-2017)

3 EUROPE GRANULOCYTE-COLONY STIMULATING FACTOR (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Granulocyte-Colony Stimulating Factor Sales and Value (2012-2017)
  3.1.1 Europe Granulocyte-Colony Stimulating Factor Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
3.2 Europe Granulocyte-Colony Stimulating Factor Sales and Market Share by Type
3.3 Europe Granulocyte-Colony Stimulating Factor Sales and Market Share by Application
3.4 Europe Granulocyte-Colony Stimulating Factor Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Granulocyte-Colony Stimulating Factor Sales Volume by Countries (2012-2017)
  3.4.2 Europe Granulocyte-Colony Stimulating Factor Revenue by Countries (2012-2017)
  3.4.3 Germany Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  3.4.4 France Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  3.4.5 UK Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  3.4.6 Russia Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  3.4.7 Italy Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)

4 MIDDLE EAST GRANULOCYTE-COLONY STIMULATING FACTOR (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Granulocyte-Colony Stimulating Factor Sales and Value (2012-2017)
  4.1.1 Middle East Granulocyte-Colony Stimulating Factor Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
4.2 Middle East Granulocyte-Colony Stimulating Factor Sales and Market Share by Type
4.3 Middle East Granulocyte-Colony Stimulating Factor Sales and Market Share by Application
4.4 Middle East Granulocyte-Colony Stimulating Factor Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Granulocyte-Colony Stimulating Factor Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Granulocyte-Colony Stimulating Factor Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  4.4.4 Israel Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  4.4.5 UAE Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  4.4.6 Iran Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)

5 AFRICA GRANULOCYTE-COLONY STIMULATING FACTOR (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Granulocyte-Colony Stimulating Factor Sales and Value (2012-2017)
  5.1.1 Africa Granulocyte-Colony Stimulating Factor Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
5.2 Africa Granulocyte-Colony Stimulating Factor Sales and Market Share by Type
5.3 Africa Granulocyte-Colony Stimulating Factor Sales and Market Share by Application
5.4 Africa Granulocyte-Colony Stimulating Factor Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Granulocyte-Colony Stimulating Factor Sales Volume by Countries (2012-2017)
  5.4.2 Africa Granulocyte-Colony Stimulating Factor Revenue by Countries (2012-2017)
  5.4.3 South Africa Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2012-2017)

6 EMEA GRANULOCYTE-COLONY STIMULATING FACTOR MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Biocad
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Granulocyte-Colony Stimulating Factor Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Biocad Granulocyte-Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Celltrion Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Granulocyte-Colony Stimulating Factor Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Celltrion Inc Granulocyte-Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Dong-A Socio Group
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Granulocyte-Colony Stimulating Factor Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Granulocyte-Colony Stimulating Factor Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Inc Granulocyte-Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Intas Pharmaceuticals Ltd
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Granulocyte-Colony Stimulating Factor Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Intas Pharmaceuticals Ltd Granulocyte-Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Granulocyte-Colony Stimulating Factor Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis Granulocyte-Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Stada Arzneimittel AG
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Granulocyte-Colony Stimulating Factor Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Stada Arzneimittel AG Granulocyte-Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceutical Industries Ltd
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Granulocyte-Colony Stimulating Factor Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Teva Pharmaceutical Industries Ltd Granulocyte-Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Amgen Inc
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Granulocyte-Colony Stimulating Factor Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Amgen Inc Granulocyte-Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Biocon
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Granulocyte-Colony Stimulating Factor Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Biocon Granulocyte-Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Dr. Reddy's Laboratories
6.12 Mylan
6.13 Merck KGaA

7 GRANULOCYTE-COLONY STIMULATING FACTOR MANUFACTURING COST ANALYSIS

7.1 Granulocyte-Colony Stimulating Factor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Granulocyte-Colony Stimulating Factor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Granulocyte-Colony Stimulating Factor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Granulocyte-Colony Stimulating Factor Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA GRANULOCYTE-COLONY STIMULATING FACTOR MARKET FORECAST (2017-2022)

11.1 EMEA Granulocyte-Colony Stimulating Factor Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Granulocyte-Colony Stimulating Factor Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Granulocyte-Colony Stimulating Factor Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Granulocyte-Colony Stimulating Factor Price and Trend Forecast (2017-2022)
11.2 EMEA Granulocyte-Colony Stimulating Factor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Granulocyte-Colony Stimulating Factor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Granulocyte-Colony Stimulating Factor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Granulocyte-Colony Stimulating Factor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Granulocyte-Colony Stimulating Factor Sales Forecast by Type (2017-2022)
11.7 EMEA Granulocyte-Colony Stimulating Factor Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Granulocyte-Colony Stimulating Factor
Figure EMEA Granulocyte-Colony Stimulating Factor Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Granulocyte-Colony Stimulating Factor Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsule Product Picture
Figure Tablet Product Picture
Figure Others Product Picture
Figure EMEA Granulocyte-Colony Stimulating Factor Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Granulocyte-Colony Stimulating Factor by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Blood Disorders Examples
Table Key Downstream Customer in Blood Disorders
Figure Growth Hormone Deficiencies Examples
Table Key Downstream Customer in Growth Hormone Deficiencies
Figure Chronic and Autoimmune Disorders Examples
Table Key Downstream Customer in Chronic and Autoimmune Disorders
Figure Other Applications Examples
Table Key Downstream Customer in Other Applications
Figure EMEA Granulocyte-Colony Stimulating Factor Market Size (Million USD) by Region (2012-2022)
Figure Europe Granulocyte-Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Granulocyte-Colony Stimulating Factor Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Granulocyte-Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Granulocyte-Colony Stimulating Factor Revenue (Million USD) Status and Forecast by Countries
Figure Africa Granulocyte-Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Granulocyte-Colony Stimulating Factor Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Granulocyte-Colony Stimulating Factor Sales Volume and Growth Rate (2012-2022)
Figure EMEA Granulocyte-Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Granulocyte-Colony Stimulating Factor Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Sales Share by Players (2012-2017)
Figure 2016 Granulocyte-Colony Stimulating Factor Sales Share by Players
Figure 2017 Granulocyte-Colony Stimulating Factor Sales Share by Players
Figure EMEA Granulocyte-Colony Stimulating Factor Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Revenue (Million USD) by Players (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Revenue Share by Players (2012-2017)
Table 2016 EMEA Granulocyte-Colony Stimulating Factor Revenue Share by Players
Table 2017 EMEA Granulocyte-Colony Stimulating Factor Revenue Share by Players
Table EMEA Granulocyte-Colony Stimulating Factor Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Sales Share by Type (2012-2017)
Figure Sales Market Share of Granulocyte-Colony Stimulating Factor by Type (2012-2017)
Figure EMEA Granulocyte-Colony Stimulating Factor Sales Market Share by Type (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Granulocyte-Colony Stimulating Factor by Type in 2016
Table EMEA Granulocyte-Colony Stimulating Factor Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Sales Share by Application (2012-2017)
Figure Sales Market Share of Granulocyte-Colony Stimulating Factor by Application (2012-2017)
Figure EMEA Granulocyte-Colony Stimulating Factor Sales Market Share by Application in 2016
Table EMEA Granulocyte-Colony Stimulating Factor Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Sales Share by Region (2012-2017)
Figure Sales Market Share of Granulocyte-Colony Stimulating Factor by Region (2012-2017)
Figure EMEA Granulocyte-Colony Stimulating Factor Sales Market Share in 2016
Table EMEA Granulocyte-Colony Stimulating Factor Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Granulocyte-Colony Stimulating Factor Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Granulocyte-Colony Stimulating Factor by Region (2012-2017)
Figure EMEA Granulocyte-Colony Stimulating Factor Revenue Market Share Regions in 2016
Table EMEA Granulocyte-Colony Stimulating Factor Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2012-2017)
Table Europe Granulocyte-Colony Stimulating Factor Sales (K MT) by Type (2012-2017)
Table Europe Granulocyte-Colony Stimulating Factor Market Share by Type (2012-2017)
Figure Europe Granulocyte-Colony Stimulating Factor Market Share by Type in 2016
Table Europe Granulocyte-Colony Stimulating Factor Sales (K MT) by Application (2012-2017)
Table Europe Granulocyte-Colony Stimulating Factor Market Share by Application (2012-2017)
Figure Europe Granulocyte-Colony Stimulating Factor Market Share by Application in 2016
Table Europe Granulocyte-Colony Stimulating Factor Sales (K MT) by Countries (2012-2017)
Table Europe Granulocyte-Colony Stimulating Factor Sales Market Share by Countries (2012-2017)
Figure Europe Granulocyte-Colony Stimulating Factor Sales Market Share by Countries (2012-2017)
Figure Europe Granulocyte-Colony Stimulating Factor Sales Market Share by Countries in 2016
Table Europe Granulocyte-Colony Stimulating Factor Revenue (Million USD) by Countries (2012-2017)
Table Europe Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Europe Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Europe Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries in 2016
Figure Germany Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure France Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure UK Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Granulocyte-Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Granulocyte-Colony Stimulating Factor Sales (K MT) by Type (2012-2017)
Table Middle East Granulocyte-Colony Stimulating Factor Market Share by Type (2012-2017)
Figure Middle East Granulocyte-Colony Stimulating Factor Market Share by Type (2012-2017)
Table Middle East Granulocyte-Colony Stimulating Factor Sales (K MT) by Applications (2012-2017)
Table Middle East Granulocyte-Colony Stimulating Factor Market Share by Applications (2012-2017)
Figure Middle East Granulocyte-Colony Stimulating Factor Sales Market Share by Application in 2016
Table Middle East Granulocyte-Colony Stimulating Factor Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Granulocyte-Colony Stimulating Factor Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Granulocyte-Colony Stimulating Factor Sales Volume Market Share by Countries in 2016
Table Middle East Granulocyte-Colony Stimulating Factor Revenue (Million USD) by Countries (2012-2017)
Table Middle East Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Middle East Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Middle East Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries in 2016
Figure Saudi Arabia Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Granulocyte-Colony Stimulating Factor Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Granulocyte-Colony Stimulating Factor Sales (K MT) by Type (2012-2017)
Table Africa Granulocyte-Colony Stimulating Factor Sales Market Share by Type (2012-2017)
Figure Africa Granulocyte-Colony Stimulating Factor Sales Market Share by Type (2012-2017)
Figure Africa Granulocyte-Colony Stimulating Factor Sales Market Share by Type in 2016
Table Africa Granulocyte-Colony Stimulating Factor Sales (K MT) by Application (2012-2017)
Table Africa Granulocyte-Colony Stimulating Factor Sales Market Share by Application (2012-2017)
Figure Africa Granulocyte-Colony Stimulating Factor Sales Market Share by Application (2012-2017)
Table Africa Granulocyte-Colony Stimulating Factor Sales Volume (K MT) by Countries (2012-2017)
Table Africa Granulocyte-Colony Stimulating Factor Sales Market Share by Countries (2012-2017)
Figure Africa Granulocyte-Colony Stimulating Factor Sales Market Share by Countries (2012-2017)
Figure Africa Granulocyte-Colony Stimulating Factor Sales Market Share by Countries in 2016
Table Africa Granulocyte-Colony Stimulating Factor Revenue (Million USD) by Countries (2012-2017)
Table Africa Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Africa Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries (2012-2017)
Figure Africa Granulocyte-Colony Stimulating Factor Revenue Market Share by Countries in 2016
Figure South Africa Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Table Biocad Granulocyte-Colony Stimulating Factor Basic Information List
Table Biocad Granulocyte-Colony Stimulating Factor Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biocad Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Biocad Granulocyte-Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Biocad Granulocyte-Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Celltrion Inc Granulocyte-Colony Stimulating Factor Basic Information List
Table Celltrion Inc Granulocyte-Colony Stimulating Factor Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celltrion Inc Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Celltrion Inc Granulocyte-Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Celltrion Inc Granulocyte-Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Dong-A Socio Group Granulocyte-Colony Stimulating Factor Basic Information List
Table Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Dong-A Socio Group Granulocyte-Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Pfizer Inc Granulocyte-Colony Stimulating Factor Basic Information List
Table Pfizer Inc Granulocyte-Colony Stimulating Factor Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Inc Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Inc Granulocyte-Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc Granulocyte-Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Intas Pharmaceuticals Ltd Granulocyte-Colony Stimulating Factor Basic Information List
Table Intas Pharmaceuticals Ltd Granulocyte-Colony Stimulating Factor Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Intas Pharmaceuticals Ltd Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Intas Pharmaceuticals Ltd Granulocyte-Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Intas Pharmaceuticals Ltd Granulocyte-Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Novartis Granulocyte-Colony Stimulating Factor Basic Information List
Table Novartis Granulocyte-Colony Stimulating Factor Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Novartis Granulocyte-Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Novartis Granulocyte-Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Stada Arzneimittel AG Granulocyte-Colony Stimulating Factor Basic Information List
Table Stada Arzneimittel AG Granulocyte-Colony Stimulating Factor Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Stada Arzneimittel AG Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Stada Arzneimittel AG Granulocyte-Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Stada Arzneimittel AG Granulocyte-Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Teva Pharmaceutical Industries Ltd Granulocyte-Colony Stimulating Factor Basic Information List
Table Teva Pharmaceutical Industries Ltd Granulocyte-Colony Stimulating Factor Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Granulocyte-Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Granulocyte-Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Amgen Inc Granulocyte-Colony Stimulating Factor Basic Information List
Table Amgen Inc Granulocyte-Colony Stimulating Factor Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amgen Inc Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Amgen Inc Granulocyte-Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Amgen Inc Granulocyte-Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Biocon Granulocyte-Colony Stimulating Factor Basic Information List
Table Biocon Granulocyte-Colony Stimulating Factor Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biocon Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate (2012-2017)
Figure Biocon Granulocyte-Colony Stimulating Factor Sales Market Share in EMEA (2012-2017)
Figure Biocon Granulocyte-Colony Stimulating Factor Revenue Market Share in EMEA (2012-2017)
Table Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Basic Information List
Table Mylan Granulocyte-Colony Stimulating Factor Basic Information List
Table Merck KGaA Granulocyte-Colony Stimulating Factor Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Granulocyte-Colony Stimulating Factor
Figure Manufacturing Process Analysis of Granulocyte-Colony Stimulating Factor
Figure Granulocyte-Colony Stimulating Factor Industrial Chain Analysis
Table Raw Materials Sources of Granulocyte-Colony Stimulating Factor Major Manufacturers in 2016
Table Major Buyers of Granulocyte-Colony Stimulating Factor
Table Distributors/Traders List
Figure EMEA Granulocyte-Colony Stimulating Factor Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Granulocyte-Colony Stimulating Factor Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Granulocyte-Colony Stimulating Factor Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Granulocyte-Colony Stimulating Factor Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Granulocyte-Colony Stimulating Factor Sales Market Share Forecast by Region (2017-2022)
Table EMEA Granulocyte-Colony Stimulating Factor Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Granulocyte-Colony Stimulating Factor Revenue Market Share Forecast by Region (2017-2022)
Table Europe Granulocyte-Colony Stimulating Factor Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Granulocyte-Colony Stimulating Factor Sales Market Share Forecast by Countries (2017-2022)
Table Europe Granulocyte-Colony Stimulating Factor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Granulocyte-Colony Stimulating Factor Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Granulocyte-Colony Stimulating Factor Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Granulocyte-Colony Stimulating Factor Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Granulocyte-Colony Stimulating Factor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Granulocyte-Colony Stimulating Factor Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Granulocyte-Colony Stimulating Factor Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Granulocyte-Colony Stimulating Factor Sales Market Share Forecast by Countries (2017-2022)
Table Africa Granulocyte-Colony Stimulating Factor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Granulocyte-Colony Stimulating Factor Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Granulocyte-Colony Stimulating Factor Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Granulocyte-Colony Stimulating Factor Sales Market Share Forecast by Type (2017-2022)
Table EMEA Granulocyte-Colony Stimulating Factor Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Granulocyte-Colony Stimulating Factor Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories